Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

J&J’s Darzalex cuts risk of disease progression and death by 50%, new study shows

December 13, 2017 Research and Development Genmab, J&J, JJ, Janssen, Johnson & Johnson, darzalex, multiple myeloma, pharma

Johnson and Johnson has revealed data which demonstrates that Darzalex (daratumumab), when combined with a regimen of bortezomib, melphalan and …
News
teva_canada

Tumultuous times at Teva continue, with Chairman exit

December 13, 2017 Medical Communications, Research and Development Teva, biotech, drugs, pharma, pharmaceutical

In the latest addition to a number of high profile exits from Teva, previous interim Chief Executive and the company’s …
News
shutterstock_212035546

Single, high-dose vaccine could provide better protection against cholera outbreaks, new research shows

December 12, 2017 Manufacturing and Production, Research and Development Africa, Asia, Caribbean, Cholera, Vaccine, paxvax, pharma

A team of researchers at the University of Maryland School of Medicine (UMSOM) has been assessing the effectiveness of a …
News
brainss

Ionis scores huge breakthrough in Huntington’s, Roche licenses drug

December 12, 2017 Manufacturing and Production, Research and Development Ionis, Roche, biotech, drugs, pharma, pharmaceutical

Ionis Pharmaceuticals has revealed findings from its Phase 1/2a study into a treatment for Huntington’s disease and the strong data …
News

Exscientia appoints Oxford Innovation Sciences founder and ex-Lansdowne CEO as Deputy Chairman

December 11, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alex Snow, Exscientia, appointment

Exscientia, an Oxford-based drug design firm which has made headlines this year for its collaboration with GlaxoSmithKline to leverage its …
Appointment
hands-600497_960_720

To succeed in emerging market medicine, anticipation and innovation are essential

December 11, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abbott, biotech, drugs, emerging markets, pharma, pharmaceutical

Andrew Lane, Executive Vice President of Established Pharmaceuticals at Abbott, discusses the key steps to be taken when reaching out …
Feature
lilly_entrance_web

Cyramza fails to improve overall survival in gastric cancer, Lilly scraps regulatory plans

December 11, 2017 Research and Development, Sales and Marketing Cancer, Eli Lilly, cyramza, gastric cancer, pharma

Eli Lilly has unveiled Phase 3 results which reveal that its VEGF Receptor 2 antagonist Cyramza (ramucirumab) met its primary …
News
top_ten_1

Top Ten most popular articles on Pharmafile.com this week

December 8, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, most read news, pharma, pharmaceutical, top ten

Despite us nearing the end of the year, the news has not been slowing down at all. Headlines across Europe …
News
roche_close

Roche Tecentriq combo effective, but is it enough?

December 8, 2017 Medical Communications, Research and Development Roche, biotech, drugs, pharma, pharmaceutical, tecentriq

When Roche announced that its combination treatment of Tecentriq, alongside its own drug Avastin and chemotherapy, successfully extended progression-free survival …
News
upwards_graph

Sage Therapeutics stock pops on depression P2 results

December 8, 2017 Medical Communications, Research and Development Sage Therapeutics, biotech, drugs, pharma, pharmaceutical

Sage Therapeutics’ stock rocketed after it announced that Phase 2 results for its treatment for major depressive disorder (MDD) were …
News
james-levine-11206608

Fondation Ipsen announces Dr James Levine as new President

December 7, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Fondation Ipsen has announced its appointment of Dr James A Levine as its new President. The organisation was set up …
Appointment

FDA access programmes shaved up to a year off drug approval times, new study shows

December 7, 2017 Research and Development, Sales and Marketing FDA, market access, pharma

A research letter published this week has suggested that the FDA initiatives to accelerate drug approvals in the US could …
News
dna-163466

Getting precision treatments over the line will be a team effort, not an individual bolt for glory

December 7, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Prostate Cancer UK, biotech, drugs, pharma, pharmaceutical, prostate cancer

We’ve finally reached the starter’s block when it comes to precision medicine approaches to prostate cancer, but Dr Matthew Hobbs, …
Feature
novartislr

Novartis Kisqali improves PFS in younger women

December 7, 2017 Research and Development Kisqali, Novartis, biotech, drugs, pharma, pharmaceutical

A Phase 3 trial looking at the use of Kisqali (ribociclib) to treat premenopausal or perimenopausal women with hormone-receptor positive, …
News
roche__tree

Roche’s haemophilia A drug shows meaningful bleed control in P3

December 7, 2017 Research and Development Roche, haemophilia, pharma

Roche has unveiled new Phase 3 data for its haemophilia A treatment Helimbra (emicizumab) in patients over 12 years of …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025